OakChart

OrthoPediatrics corp

KIDSHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 9:59 AM ET

33.69+0.21 (0.63%)
2026-11-11 16:00 CET
Market cap
874.18 USD m
Revenue, TTM
264.14 USD m
Net income, TTM
-33.88 USD m
Free cash flow, TTM
2.89 USD m
EPS diluted, TTM
-1.42
P/E
-
Compare

Price

KIDS against its 20, 50 and 200-day averages
2050200missearnings
20.0025.0030.0035.00897K1.8MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26KIDSclose 33.6920-day 28.2350-day 24.68200-day 20.1333.69

2.4% under 34.53 on 4 Nov 2026. Last 15 sessions, 46.6% high to low

Profile

KIDS
52-week range, 96% of the way up
14.4234.53

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter on August 31, 2006 and is headquartered in Warsaw, IN.

IndexRUT
Employees602
IPOOct 12, 2017
Beta0.86
ATR, 14d1.51
Rel volume0.13
Short float4.13%
Insider own30.31%
Inst own68.33%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap879.66M
Enterprise Value940.59M
Income-33.88M
Sales264.14M
Book/sh12.99
Cash/sh1.72
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees602
IPOOct 12, 2017

Ratios

P/E-
Forward P/E-
PEG-
P/S3.33
P/B2.59
P/C19.57
P/FCF304.38
EV/EBITDA746.50
EV/Sales3.56
Quick Ratio2.00
Current Ratio4.55
Debt/Eq0.31
LT Debt/Eq0.30
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.42
EPS next Y-0.79
EPS next Q-0.21
EPS this Y28.74%
EPS next Y34.16%
EPS next 5Y40.17%
EPS past 3/5Y- 1.52%
Sales past 3/5Y24.56% 27.16%
EPS Y/Y TTM27.21%
Sales Y/Y TTM16.15%
EPS Q/Q50.86%
Sales Q/Q18.63%
EarningsOct 27 AMC
EPS/Sales Surpr.-16.66% 6.08%

Ownership

Insider Own30.31%
Insider Trans-20.97%
Inst Own68.33%
Inst Trans3.80%
ROA-6.76%
ROE-9.84%
ROIC-7.69%
Gross Margin65.14%
Oper. Margin-8.15%
Profit Margin-12.83%
SMA2019.34%
SMA5036.50%
SMA20067.34%
Trades-

Technical

Shs Outstand26.12M
Shs Float18.20M
Short Float4.13%
Short Ratio2.64
Short Interest0.75M
52W High34.53 -2.43%
52W Low14.42 133.63%
Volatility5.63% 5.46%
ATR (14)1.51
RSI (14)72.66
Beta0.86
Rel Volume0.13
Avg Volume284.26K
Volume4,627

Performance

Perf Week0.54%
Perf Month53.63%
Perf Quarter34.71%
Perf Half Y89.38%
Perf YTD89.70%
Perf Year95.76%
Perf 3Y32.12%
Perf 5Y-49.51%
Perf 10Y-
Recom1.25
Target Price30.75
Prev Close33.48
Price33.69
Change %0.63%

Analyst ratings

latest 10 of 10
DateActionAnalystRating changeTargetImplied
Jan 27, 2026InitiatedTTD CowenBuy$23-31.7%
Dec 10, 2025InitiatedCCanaccord GenuityBuy$24-28.8%
Apr 07, 2025InitiatedLLake StreetBuy$37+9.8%
Jan 25, 2024DowngradeTTruistBuy → Hold$39 → $31-8.0%
Jun 14, 2021ReiteratedNNeedhamBuy$70 → $77+128.6%
Apr 02, 2020ReiteratedNNeedhamBuy$56 → $46+36.5%
Jan 08, 2020InitiatedSSunTrustBuy$54+60.3%
Jun 19, 2019InitiatedNNeedhamBuy$53+57.3%
Feb 20, 2019InitiatedJJMP SecuritiesMkt Outperform$44+30.6%
Jul 05, 2018ReiteratedPPiper JaffrayOverweight$24 → $30-11.0%

Peers

Mkt cap
TickerCompanyMkt cap
OFIXOrthofix Medical Inc298.77M
GMEDGlobus Medical Inc9.94B
ENOVEnovis Corp1.66B
ATECAlphatec Holdings Inc1.13B
SNNSmith & Nephew plc ADR12.94B
ZBHZimmer Biomet Holdings Inc20.24B
SIShoulder Innovations Inc451.51M
TMCITreace Medical Concepts Inc329.11M
SIBNSI-BONE Inc1.14B
SYKStryker Corp121.19B

Insider trading

latest 14 of 32
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Squadron Capital LLC10% OwnerSep 10 '26Sale21.01302,3696,352,7736,201,764Sep 11 08:30 AM
Pritzker Jennifer N.10% OwnerSep 10 '26Sale21.01302,3696,352,7736,201,764Sep 11 08:23 AM
Pelizzon David RDirectorSep 10 '26Sale21.01302,3696,352,7736,201,764Sep 10 04:21 PM
Squadron Capital LLC10% OwnerSep 02 '26Sale23.3522,500525,3756,504,133Sep 04 04:42 PM
Pritzker Jennifer N.10% OwnerSep 02 '26Sale23.3522,500525,3756,504,133Sep 04 04:37 PM
Pelizzon David RDirectorSep 02 '26Sale23.3522,500525,3756,504,133Sep 04 04:26 PM
Squadron Capital LLC10% OwnerAug 28 '26Sale23.04326,7007,527,1686,536,764Sep 01 06:48 PM
Squadron Capital LLC10% OwnerSep 01 '26Sale23.1010,131234,0266,526,633Sep 01 06:48 PM
Pritzker Jennifer N.10% OwnerAug 28 '26Sale23.04326,7007,527,1686,536,764Sep 01 06:39 PM
Pritzker Jennifer N.10% OwnerSep 01 '26Sale23.1010,131234,0266,526,633Sep 01 06:39 PM
Pelizzon David RDirectorAug 28 '26Sale23.04326,7007,527,1686,536,764Sep 01 05:13 PM
Pelizzon David RDirectorSep 01 '26Sale23.1010,131234,0266,526,633Sep 01 05:13 PM
Pritzker Jennifer N.10% OwnerAug 26 '26Sale24.2818,000437,0406,863,464Aug 26 06:30 PM
Pritzker Jennifer N.10% OwnerAug 25 '26Sale24.7416,300403,2626,881,464Aug 26 06:30 PM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFACU.S. Core Equity 2 Portfolio-ETF Class Shares-
DFMCU.S. Micro Cap Portfolio ETF Class Shares-
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 206
  • OrthoPediatrics Announces Full Commercial Launch of VerteGlide Spinal Growth Guidance System (GlobeNewswire) +7.02%
  • OrthoPediatrics to Participate in Upcoming Conferences (GlobeNewswire)
  • OrthoPediatrics: Q3 Earnings Snapshot (Associated Press) +29.30%
  • OrthoPediatrics Accelerates To 19% Growth And Raises Guidance Again, But The Flat EBITDA Outlook Keeps Margin Leverage In Question (Earnings Whispers)
  • OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance (GlobeNewswire)
  • Loading…
  • OrthoPediatrics Announces FDA 510(k) Clearance of PNP Femur Retrograde Nail System and Completes First Implantations (GlobeNewswire)
  • OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026 (GlobeNewswire)
  • OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB Knee 'TractorFIX (GlobeNewswire)
  • OrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques Course (GlobeNewswire)
  • OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations (GlobeNewswire)
  • Dell and 4 More Stocks See Action From Activist Investors (Barrons.com)
  • OrthoPediatrics Announces Full Commercial Launch of 3P Pediatric Plating Platform Hip System Following More Than 350 Successful Implantations (GlobeNewswire)
  • OrthoPediatrics Corp (KIDS) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA ... (GuruFocus.com) +6.85%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-27-0.250-0.214-0.25072.6668.507
2026Q22026-08-04-0.300-0.302-0.29870.5168.219
2026Q12026-04-30-0.450-0.455-0.45159.3658.299
2025Q42026-02-26-0.430-0.288-0.42961.6160.169
2025Q32025-10-28-0.240-0.258-0.50061.2562.117
2025Q22025-08-05-0.110-0.290-0.30361.0861.477
2025Q12025-05-07-0.390-0.439-0.45952.4151.687
2024Q42025-03-04-0.290-0.301-0.69452.6751.326
2024Q32024-11-06-0.180-0.227-0.34254.5753.736
2024Q22024-08-05-0.230-0.263-0.26152.8052.527
2024Q12024-05-06-0.300-0.405-0.34244.6941.787
2023Q42024-03-06-0.230-0.269-0.29437.6137.737
2023Q32023-11-06-0.130-0.213-0.20239.9740.377
2023Q22023-07-31-0.190-0.205-0.12739.5639.137
2023Q12023-05-01-0.290-0.352-0.30231.5929.317
2022Q42023-02-28-0.320-0.229-0.34330.9931.007

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-0.870-0.826-0.93972.5571.94
2020FY-1.820-1.342-1.82571.0872.68
2021FY-0.750-1.024-0.84498.0597.93
2022FY-0.820-0.7110.059122.29122.3
2023FY-0.850-0.887-0.925148.73148.83
2024FY-1.010-1.130-1.639204.73202.98
2025FY-1.690-1.253-1.690236.35234.88
2026FY--1.204--271.6
2027FY--0.793--304.47
2028FY--0.362--339.8
2029FY--0.650--380.3
2030FY-0.910--415.6

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2883069.0568.5069.45
2026Q4S2026-10-2780068.6067.9069.40
2026Q4S2026-10-1580068.6067.9069.40
2026Q4S2026-10-1390068.6167.9069.40
2026Q4S2026-09-1190068.6167.9069.40
2026Q4S2026-08-2090068.6167.9069.40
2026Q4S2026-08-1990068.6167.9069.40
2026Q4S2026-08-1190068.6167.9069.40
2026Q4S2026-08-0590068.6167.9069.40
2026Q4S2026-07-1590068.3367.6068.90
2026Q4S2026-07-1091268.3467.6068.90
2026Q4S2026-06-0991268.3467.6068.90
2026Q4S2026-05-1391268.3467.6068.90
2026Q4S2026-05-0196368.3467.6068.90

Estimate history

EPS, annual-5.86-0.957-0.939-1.825-0.8440.059-0.925-1.639-1.69-1.4231
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.342-0.694-0.459-0.303-0.5-0.429-0.451-0.298-0.246
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual45.6257.55972.55271.07898.049122.289148.732204.727236.348264.14
Period201720182019202020212022202320242025TTM
Sales, quarterly54.57352.66752.41161.08261.2561.60559.36270.50872.661
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual12.62214.53816.72319.5619.67722.87823.37824.21825.09426.115
Period201720182019202020212022202320242025MRQ
Shares, quarterly24.21424.21824.82825.07325.07725.09425.60526.11126.115
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue264.14236.35204.73148.73122.2998.0571.0872.5557.56
Cost of Goods Sold Incl. D&A92.0883.8774.8954.8644.7335.3323.9522.5717.39
Gross Profit172.06152.47129.8493.8777.5662.7247.1249.9840.17
Selling, General and Administrative Excl. Other193.58181.47159.36119.6398.9780.6067.2058.3249.72
Research and Development9.289.1011.0310.208.015.545.275.754.73
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-21.52-29.00-29.52-25.77-21.41-17.87-20.08-8.34-9.55
Interest Expense9.186.002.62-2.422.253.413.542.25
Unusual Expense2.4610.248.72-2.00-21.94-1.6510.200.740.00
Net Income Before Taxes-33.59-39.19-41.93-21.31-3.69-17.39-33.67-12.69-12.03
Income Taxes0.290.46-4.11-0.34-4.95-1.13-0.720.000.00
Consolidated Net Income-33.88-39.65-37.82-20.971.24-16.26-32.94-12.69-12.03
Net Income From Continuing Operations-33.88-39.65-37.82-20.971.24-16.26-32.94-12.69-12.03
Net Income-33.88-39.65-37.82-20.971.24-16.26-32.94-13.73-12.03
EPS (Recurring)-1.33-1.38-1.37-0.99-0.67-0.90-1.43-0.90-0.96
EPS (Basic, Before Extraordinaries)-1.42-1.69-1.64-0.930.06-0.84-1.82-0.94-0.96
EPS (Diluted)-1.42-1.69-1.64-0.930.06-0.84-1.82-0.94-0.96
EBITDA1.26-8.81-10.76-8.38-8.31-7.20-12.17-3.70-6.66
Non-Operating Income (Expense)-0.426.05-1.072.46-1.801.080.02-0.07-0.22
Other After Tax Adjustments0.000.000.000.00-0.020.000.000.000.00
Stock Option Compensation Expense12.3714.0410.708.325.280.004.522.603.19
Price To Earnings Ratio----107.09----
Price To Sales Ratio2.041.762.614.966.8111.7610.489.477.62
Gross Margin65.1464.5163.4263.1163.4363.9766.3068.8969.78
Operating Margin-8.15-12.27-14.42-17.32-17.51-18.23-28.25-11.50-16.60
Net Margin-12.83-16.78-18.47-14.101.01-16.58-46.35-18.93-20.89
Shares Outstanding26.1225.0924.2223.3822.8819.6819.5616.7214.54
Market Capitalization874.18874.18561.32759.22909.481,177.95806.63774.72499.06

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue72.6670.5159.3661.6061.2561.0852.4152.67
Cost of Goods Sold Incl. D&A24.3123.8521.6922.2321.2722.2319.2021.09
Gross Profit48.3546.6637.6739.3839.9838.8533.2131.57
Selling, General and Administrative Excl. Other51.9750.7346.0044.8844.8446.5344.1640.14
Research and Development2.462.332.232.262.332.162.352.92
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-3.61-4.07-8.34-5.51-4.87-7.69-10.94-8.57
Interest Expense2.622.532.101.931.821.121.131.32
Unusual Expense-0.200.000.002.674.562.970.045.49
Net Income Before Taxes-6.04-6.93-10.86-9.76-11.90-7.06-10.46-16.41
Income Taxes-0.110.23-0.170.34-0.120.050.20-0.34
Consolidated Net Income-5.93-7.16-10.69-10.10-11.77-7.11-10.66-16.07
Net Income From Continuing Operations-5.93-7.16-10.69-10.10-11.77-7.11-10.66-16.07
Net Income-5.93-7.16-10.69-10.10-11.77-7.11-10.66-16.07
EPS (Recurring)-0.25-0.30-0.45-0.35-0.36-0.21-0.46-0.53
EPS (Basic, Before Extraordinaries)-0.25-0.30-0.45-0.43-0.50-0.30-0.46-0.69
EPS (Diluted)-0.25-0.30-0.45-0.43-0.50-0.30-0.46-0.69
EBITDA2.011.64-2.610.230.43-2.52-5.89-4.57
Non-Operating Income (Expense)-0.01-0.33-0.420.34-0.654.711.64-1.03
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.493.313.152.423.364.153.053.07
Price To Sales Ratio2.041.821.541.771.922.282.692.62
Gross Margin66.5566.1863.4663.9265.2763.6063.3759.95
Operating Margin-4.97-5.77-14.04-8.94-7.94-12.58-20.88-16.26
Net Margin-8.16-10.16-18.00-16.40-19.22-11.65-20.34-30.51
Shares Outstanding26.1226.1125.6025.0925.0825.0724.8324.22
Market Capitalization874.18491.35401.17445.37464.61532.04598.18561.32

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments62.9170.7982.28119.7654.9185.2772.0360.6942.58
Short Term Receivables53.8442.3634.6224.8017.9417.5516.579.505.60
Inventories133.79117.00105.8578.1957.5752.9938.0025.7120.55
Other Current Assets5.887.023.753.973.232.621.461.260.83
Total Current Assets256.42237.17226.50226.72133.65158.43128.0697.1669.56
Net Property, Plant & Equipment61.6058.8341.0534.2928.5227.2321.3512.7710.39
Total Investments and Advances3.632.181.850.000.000.000.000.000.00
Intangible Assets186.98175.02168.26166.72142.11134.7632.752.182.35
Deferred Tax Assets14.4510.4910.8411.494.134.420.83--
Other Assets-0.000.001.080.000.000.000.000.000.00
Total Assets523.08483.70449.59439.21308.40324.83182.99112.1182.30
Short Term Debt Incl. Current Port. of LT Debt5.423.6310.307.9613.0012.360.120.120.11
Accounts Payable18.798.9112.6511.159.3210.046.473.975.50
Other Current Liabilities21.9921.4318.7211.767.3912.637.075.133.86
Total Current Liabilities46.2033.9641.6730.8729.7135.0313.669.229.47
Long Term Debt111.6681.0713.468.7815.5114.1526.1321.1625.34
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities18.0313.8816.3217.448.9010.170.83--
Other Liabilities0.600.231.113.4728.9130.710.000.000.00
Total Liabilities176.48129.1472.5660.5683.0390.0640.6230.3734.81
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity346.60354.57377.02378.65225.37234.77142.3681.7347.49
Total Shareholders Equity346.60354.57377.02378.65225.37234.77142.3681.7347.49
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity346.60354.57377.02378.65225.37234.77142.3681.7347.49
Total Liabilities & Stockholders Equity523.08483.70449.59439.21308.40324.83182.99112.1182.30
Book Value Per Share13.8114.6416.1316.5511.4512.008.515.623.76
Tangible Book Value Per Share6.367.418.939.264.235.116.555.473.58
Full-Time Employees602562247203133116948069
Price to Book Ratio2.581.512.032.375.233.445.526.20-0.66
Return on Assets-7.88-8.11-4.720.33-5.14-12.67-8.60-12.37-15.81
Return on Equity-11.31-10.34-5.550.41-7.07-17.47-11.32-18.61-33.40
Return on Invested Capital-8.65-8.68-5.370.32-6.75-13.23-8.15-11.69-12.26
Quick Ratio2.653.542.904.812.563.016.597.755.18
Current Ratio5.556.985.447.344.504.529.3710.547.35

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-33.88-39.65-37.82-20.971.26-16.26-32.94-13.73-12.03
Depreciation22.6521.1219.0817.3913.1010.688.014.672.89
Other Funds (Non Cash)20.2424.6219.369.90-13.346.2012.112.673.19
Funds from Operations8.345.94-4.115.15-4.01-0.51-13.54-6.39-5.95
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital3.86-10.79-22.93-32.20-17.76-12.55-4.99-11.38-9.63
Cash from Operating Activities12.21-4.85-27.05-27.05-21.77-13.06-18.53-17.77-15.58
Capital Expenditures-11.33-13.13-14.91-18.98-10.03-16.66-11.30-12.09-5.46
Net Assets From Acquisitions-15.06-15.50-23.11-3.64-40.090.00-3.39-49.84-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments16.20-15.0024.8664.30-63.259.25-55.000.000.00
Purchase of Investments1.20-15.00-25.00-48.60-110.120.00-55.000.00-
Sale Or Maturity of Investments15.000.0049.85112.9046.879.250.000.000.00
Other Uses0.000.000.000.000.000.000.000.00-0.50
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-10.20-43.63-13.1641.68-113.37-7.41-69.69-61.92-5.96
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.02139.340.1471.8661.1443.84
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.02139.340.1471.8661.1443.84
Proceedsfrom Stock Options0.000.000.000.00139.280.0070.2160.0043.42
Issuance or Reduction of Debt, Net-3.0123.9856.639.28-0.14-0.13-25.1229.88-4.18
Change in Long Term Debt-3.0123.9856.639.28-0.14-0.13-25.1229.88-4.18
Issuance of Long Term Debt0.0025.0070.139.4231.000.000.0030.000.00
Reduction of Long Term Debt-3.01-1.02-13.49-0.14-31.14-0.13-25.12-0.12-4.18
Net Financing Active Other Cash Flow0.000.00-3.50-2.00-3.230.000.000.000.00
Other Financing Activities Uses0.000.00-3.50-2.00-3.230.000.000.000.00
Cash from Financing Activities-3.0123.9853.137.30135.970.0146.7391.0239.66
Exchange Rate Effect-0.040.35-0.170.630.62-0.66-0.400.01-
Net Change in Cash-1.03-24.1612.7522.571.46-21.13-41.9011.3418.11
Free Cash Flow2.89-15.96-41.31-43.92-31.80-21.17-29.03-29.59-20.84
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow186.06--------
Deferred Taxes & Investment Tax Credit--0.15-4.74-1.16-5.03-1.13-0.720.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments44.9447.9350.8662.9159.7972.20
Short Term Receivables59.5460.9554.4353.8451.2753.80
Inventories141.86137.57134.02133.79128.81125.27
Other Current Assets6.896.066.555.885.996.44
Total Current Assets253.24252.51245.87256.42245.85257.70
Net Property, Plant & Equipment46.9448.5548.5561.6051.2052.93
Total Investments and Advances0.000.000.003.630.000.00
Intangible Assets192.45195.03191.89186.98182.82179.05
Deferred Tax Assets---14.45--
Other Assets16.4515.3015.88-0.0013.6113.93
Total Assets509.09511.39502.19523.08493.49503.61
Short Term Debt Incl. Current Port. of LT Debt4.633.642.935.421.350.77
Accounts Payable24.4822.2419.7018.797.1612.69
Other Current Liabilities26.5226.9824.5521.9924.7225.20
Total Current Liabilities55.6352.8547.1846.2033.2338.67
Long Term Debt101.24102.42103.35111.6699.4097.23
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities3.143.313.3518.033.803.52
Other Liabilities9.729.199.590.607.748.67
Total Liabilities169.74167.77163.48176.48144.18148.09
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity339.35343.61338.71346.60349.31355.51
Total Shareholders Equity339.35343.61338.71346.60349.31355.51
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity339.35343.61338.71346.60349.31355.51
Total Liabilities & Stockholders Equity509.09511.39502.19523.08493.49503.61
Book Value Per Share12.9913.1613.2313.8113.9314.18
Tangible Book Value Per Share5.625.695.736.366.647.04
Full-Time Employees---602--
Price to Book Ratio2.581.451.151.271.311.54
Return on Assets-6.76-7.83-8.16-7.88-9.28-8.94
Return on Equity-9.84-11.36-11.57-11.31-12.67-11.49
Return on Invested Capital-1.35-1.61-2.42-2.20-2.62-1.57
Quick Ratio2.002.172.372.653.523.43
Current Ratio4.554.785.215.557.406.66

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-5.93-7.16-10.69-10.10-11.77-7.11
Depreciation5.625.715.725.605.305.17
Other Funds (Non Cash)4.894.164.107.088.435.05
Funds from Operations4.282.94-1.182.311.833.15
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.23-2.30-2.118.04-2.42-13.62
Cash from Operating Activities4.510.64-3.2910.35-0.58-10.46
Capital Expenditures-2.91-4.04-1.76-2.62-2.84-3.44
Net Assets From Acquisitions-2.470.84-6.78-6.65-8.53-0.10
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments1.248.204.752.01-15.470.00
Purchase of Investments-0.48-0.08-0.252.01-15.470.00
Sale Or Maturity of Investments1.728.285.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-4.155.00-3.79-7.26-26.84-3.54
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1.53-0.45-0.61-0.42-0.2824.80
Change in Long Term Debt-1.53-0.45-0.61-0.42-0.2824.80
Issuance of Long Term Debt0.000.000.000.000.0025.00
Reduction of Long Term Debt-1.53-0.45-0.61-0.42-0.28-0.20
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-1.53-0.45-0.61-0.42-0.2824.80
Exchange Rate Effect-0.03-0.380.310.06-0.020.38
Net Change in Cash-1.204.81-7.382.74-27.7211.18
Free Cash Flow1.59-3.41-5.059.75-3.42-13.91
Price to Free Cash Flow186.06-----

Revenue breakdown

Spine2024: 55.15M 2025: 66.05M
Sports Medicine And Other2024: 4.45M 2025: 4.00M
Trauma and Deformity2024: 145.13M 2025: 166.30M
Non-US2024: 43.56M 2025: 49.95M
United States2024: 161.16M 2025: 186.40M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.13%0.8M18.2M274.23K
2026-10-155.37%1.0M18.2M211.54K
2026-09-305.15%0.9M18.1M201.87K
2026-09-154.86%0.9M18.1M204.84K
2026-08-314.54%0.8M17.8M193.47K
2026-08-144.91%0.9M17.4M168.58K
2026-07-314.84%0.8M17.4M156.42K
2026-07-155.16%0.9M17.1M162.49K
2026-06-305.25%0.9M17.1M162.85K
2026-06-154.97%0.8M17.1M164.36K
2026-05-295.32%0.9M17.2M170.92K
2026-05-155.52%0.9M17.2M173.60K
2026-04-305.23%0.9M17.0M157.02K
2026-04-155.61%0.9M16.8M148.74K
2026-03-315.74%1.0M16.8M159.35K
2026-03-135.64%0.9M16.8M151.47K
2026-02-275.19%0.9M16.8M151.83K
2026-02-135.57%0.9M16.7M172.77K
2026-01-305.94%1.0M16.7M177.86K
2026-01-156.07%1.0M16.7M192.52K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.5019.2024.000.008.1270.000.000.923-0.4450.008
call15.0016.7021.500.006.8520.000.000.899-0.4590.009
call17.5014.3019.000.005.8200.000.000.873-0.4600.011
call20.0011.8016.503.504.9487.000.000.846-0.4510.013
call22.509.3014.008.704.1853.000.000.814-0.4350.014
call25.006.8011.506.003.50034.000.000.779-0.4120.016
call30.003.405.502.501.6311550.000.763-0.1130.016
call35.000.004.900.651.4284900.000.483-0.1750.022
call40.000.004.900.002.1400.000.000.371-0.2270.021
call45.000.004.900.002.6690.000.000.325-0.2700.020
put12.500.004.900.004.0630.000.00-0.035-0.0870.004
put15.000.004.900.003.3910.000.00-0.042-0.0850.005
put17.500.004.900.002.8260.000.00-0.051-0.0830.006
put20.000.004.900.402.33529.000.00-0.062-0.0790.007
put22.500.004.901.001.8972.000.00-0.075-0.0750.008
put25.000.004.900.051.49776.000.00-0.094-0.0700.009
put30.000.001.000.103.40928.000.00-0.304-0.3520.019
put35.000.104.900.001.8930.000.00-0.517-0.1710.022
put40.003.508.400.001.9430.000.00-0.525-0.3870.021
put45.008.5013.400.002.4790.000.00-0.563-0.4490.021

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-09-11SCHEDULE 13D/ASEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-09-01SCHEDULE 13D/ASEC
2026-09-014Statement of changes in beneficial ownership of securities2026-08-28SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-24144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-15SCHEDULE 13G/ASEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090021.34M9
2026-080025.41M12
2026-070000
2026-060000
2026-050000
2026-040000
2026-03001.00M5
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BROWN ADVISORY INC6.54%
BlackRock, Inc.4.96%
AIGH Capital Management LLC4.49%
BRAIDWELL LP4.28%
Granahan Investment Management, LLC4.23%
MILLENNIUM MANAGEMENT LLC3.18%
WELLINGTON MANAGEMENT GROUP LLP3.09%
VANGUARD CAPITAL MANAGEMENT LLC2.94%
Soleus Capital Management, L.P.2.85%
MORGAN STANLEY2.70%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.08%
Wasatch Micro Cap Fund1.78%
iShares Russell 2000 ETF1.73%
Brown Advisory Small-Cap Growth Fund1.37%
JNL Multi-Manager Small Cap Growth Fund1.07%
SmallCap Growth Fund I1.01%
VANGUARD EXTENDED MARKET INDEX FUND0.80%
Embark Small Cap Equity Fund0.76%
Fidelity Small Cap Index Fund0.75%
Victory Small Cap Stock Fund0.74%

OakChart. KIDS. Cached 15 minutes.